| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |